The capabilities are genuinely differentiated: a) ADC: Filed 3 payload DMFs in FY26, completed first cGMP bioconjugation campaign at NJ Bio (US facility), expanding with $10 Mn capex for Phase 2/validation readiness, traction in exatecan-linked platforms b) Oligonucleotide : cGMP building block facility under validation through the Sapala platform, follow-on purchase orders received c) Small Molecule CDMO: 140+ active projects, 70%+ from commercial products, 90%+ reload conversion rate d) Phase 3 pipeline: 10 programs including 1 under priority review and 1 awaiting clinical data readout However, FY26 was operationally challenging
Wang et al., 2021), but in addition, we have also noticed a significant increase in GLP-1 secretion in the pancreatic islets, which has been ignored in previous studies
Overweight and obesity: a brief challenge on prevalence, complications and physical activity among men and women
While you take a GLP-1, strength training can support muscle and performance, cardio can improve heart health and stamina, and both can improve daily energy and mood